Other factors impacting SMA’s severity and symptoms involve positive or negative disease modifiers, such as rare SMN2 variants (e.g., c.859G  >  C) and independent factors such as plastin 3 and neurocalcin delta [14]. Here, SMN2 is linked to proximal spinal muscular atrophy.